Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diastolic blood pressure
|
1037 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 10 | 2009 | 2019 | |||||
Systolic Pressure
|
1931 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 5 | 2009 | 2018 | |||||
Adenocarcinoma of large intestine
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
Colorectal Carcinoma
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.730 | 1.000 | 4 | 2015 | 2019 | |||||
Colorectal Neoplasms
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
Malignant neoplasm of large intestine
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
Malignant tumor of colon
|
368 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 4 | 2015 | 2019 | |||||
Cholangitis, Sclerosing
|
276 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 3 | 2013 | 2017 | |||||
Diabetes Mellitus, Insulin-Dependent
|
198 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.820 | 1.000 | 3 | 2009 | 2018 | |||||
Hemoglobin measurement
|
209 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 3 | 2012 | 2017 | |||||
Platelet Count measurement
|
456 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 3 | 2011 | 2016 | |||||
Body mass index
|
2689 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 2 | 2018 | 2018 | |||||
Coronary Artery Disease
|
551 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.810 | 1.000 | 2 | 2013 | 2018 | |||||
Eosinophil count procedure
|
1133 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 2 | 2009 | 2016 | |||||
Hypothyroidism
|
185 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 2 | 2012 | 2019 | |||||
Red Blood Cell Count measurement
|
1141 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 2 | 2009 | 2019 | |||||
White Blood Cell Count procedure
|
1003 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 2 | 2016 | 2019 | |||||
Adenocarcinoma of lung (disorder)
|
111 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Ankylosing spondylitis
|
345 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Autoantibody measurement
|
5 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.800 | 1.000 | 1 | 2011 | 2018 | |||||
Autoimmune Chronic Hepatitis
|
3 | 0.572 | 0.600 | 12 | 111446804 | missense variant | T/A;C;G | snv | 0.67 | 0.720 | 1.000 | 1 | 2014 | 2017 |